Literature DB >> 23730505

The re-birth of hepatic arterial infusion for colorectal liver metastases.

Nancy E Kemeny1.   

Abstract

Entities:  

Year:  2013        PMID： 23730505      PMCID： PMC3635177          DOI： 10.3978/j.issn.2078-6891.2013.019

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  15 in total

1.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis.

Authors:  Atsushi Nanashima; Hiroaki Takeshita; Takafumi Abo; Kazuo Tou; Kenji Tanaka; Daisuke Fukuda; Masaki Kunizaki; Shigekazu Hidaka; Terumitsu Sawai
Journal:  J Gastrointest Oncol       Date:  2013-06

3.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

Authors:  Nancy E Kemeny; Donna Niedzwiecki; Donna R Hollis; Heinz-Josef Lenz; Robert S Warren; Michelle J Naughton; Jane C Weeks; Elin R Sigurdson; James E Herndon; Chunfeng Zhang; Robert J Mayer
Journal:  J Clin Oncol       Date:  2006-02-27       Impact factor: 44.544

4.  Pharmacologic rationale for regional drug delivery.

Authors:  J M Collins
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

5.  Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.

Authors:  I Durand-Zaleski; S Earlam; C Fordy; M Davies; T G Allen-Mersh
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

6.  Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.

Authors:  David J Kerr; Colin S McArdle; Jonathan Ledermann; Irving Taylor; David J Sherlock; Peter M Schlag; John Buckels; David Mayer; Dionne Cain; Richard J Stephens
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

7.  Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.

Authors:  J M G H van Riel; C J van Groeningen; J de Greve; G Gruia; H M Pinedo; G Giaccone
Journal:  Ann Oncol       Date:  2004-01       Impact factor: 32.976

8.  Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

Authors:  Nancy E Kemeny; Fidel D Huitzil Melendez; Marinela Capanu; Philip B Paty; Yuman Fong; Lawrence H Schwartz; William R Jarnagin; Dina Patel; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

9.  Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

Authors:  Irene Guthoff; Erkki Lotspeich; Claudia Fester; Inger Wallin; Miriam Schatz; Hans Ehrsson; Marko Kornmann
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

10.  Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.

Authors:  J L Boublil; G Milano; R Khater; J Bourry; A Thyss; J N Bruneton; N Renée; C Philip; M Namer
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640
View more
  1 in total

1.  Current treatment options for patients with initially unresectable isolated colorectal liver metastases.

Authors:  Ozkan Kanat
Journal:  World J Clin Oncol       Date:  2016-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.